Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001102624-14-000379
Filing Date
2014-03-14
Accepted
2014-03-14 15:26:21
Documents
13
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 BOSTON THERAPEUTICS, INC. 10-K boston10k_htm.htm 10-K 1349558
2 EXHIBIT 4.2 exh4_2.htm EX-4.2 100726
3 EXHIBIT 23.1 exh23_1.htm EX-23.1 3203
4 EXHIBIT 31.1 exh31_1.htm EX-31.1 17433
5 EXHIBIT 31.2 exh31_2.htm EX-31.2 16892
6 EXHIBIT 32.1 exh32_1.htm EX-32.1 7776
7 EXHIBIT 32.2 exh32_2.htm EX-32.2 8534
  Complete submission text file 0001102624-14-000379.txt   4340810

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT bthe-20131231.xml EX-101.INS 420578
9 XBRL TAXONOMY EXTENSION SCHEMA bthe-20131231.xsd EX-101.SCH 31489
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bthe-20131231_cal.xml EX-101.CAL 35554
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bthe-20131231_def.xml EX-101.DEF 61224
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE bthe-20131231_lab.xml EX-101.LAB 236680
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bthe-20131231_pre.xml EX-101.PRE 172636
Mailing Address 33 SOUTH COMMERCIAL STREET MANCHESTER NH 03101
Business Address 33 SOUTH COMMERCIAL STREET MANCHESTER NH 03101 978-886-0421
Boston Therapeutics, Inc. (Filer) CIK: 0001473579 (see all company filings)

EIN.: 270801073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-54586 | Film No.: 14694271
SIC: 2834 Pharmaceutical Preparations